Chinese english Germany Japanese Korea

[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]-

[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]- Struktur
252920-94-8
CAS-Nr.
252920-94-8
Englisch Name:
[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]-
Synonyma:
GW 427353;Solabegron-d8;Solabegron-d8 HCl;Solabegron 13C2 D4;LLDXOPKUNJTIRF-QFIPXVFZSA-N;Tilorone oxime dihydrochloride;inhibit,GW-427353,Inhibitor,Adrenergic Receptor,GW427353,Beta Receptor,Solabegron;[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]-;3 '- [[2 - [(2R) - 2 - (3-chlorophenyl) - 2-hydroxyethyl] amino] ethyl] amino] - [1,1' - biphenyl] - 3-carboxylic acid
CBNumber:
CB22648637
Summenformel:
C23H23ClN2O3
Molgewicht:
410.89
MOL-Datei:
252920-94-8.mol
Request For Quotation

[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]- Eigenschaften

Siedepunkt:
672.4±55.0 °C(Predicted)
Dichte
1.300±0.06 g/cm3(Predicted)
storage temp. 
4°C, protect from light
Löslichkeit
DMSO: 250 mg/mL (608.44 mM)
Aggregatzustand
Solid
pka
4.14±0.10(Predicted)

Sicherheit

[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Antidiabetic (β3 adrenoreceptor agonist).

[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

[1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 23)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
Wuhan Topule Biopharmaceutical Co., Ltd 		+8618327326525
 masar@topule.com China 8474 58
Chengdu Senior Pharma Technology Co.Ltd. +86-0838-2319818 +86-15982001943
 seniorpharma@163.com China 402 55
Aikon International Limited 025-66113011 18112977050
 cb6@aikonchem.com China 15495 58
SHANGHAI FDC-CHEMICAL CO.,LTD 021-61469567 18521078705
 sales@fdc-chemical.com China 19884 58
DC Chemicals 021-58447131 13564518121
 sales@dcchemicals.com China 9412 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767
 sales@chemegen.com China 11289 58
Shanghai Kaiwei Chemical Technology Co., Ltd. 021-58461859 15821823057
 service@aiviche.com China 49323 58
Shanghai Luofa Biochemical Technology Co., Ltd. 021-51111890 15317326293
 sales@molnova.com China 4196 58
Energy Chemical 021-58432009 400-005-6266
 marketing@energy-chemical.com China 44941 58
  • [1,1'-Biphenyl]-3-carboxylicacid,3'-[[2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]aMino]ethyl]aMino]-
  • Tilorone oxime dihydrochloride
  • LLDXOPKUNJTIRF-QFIPXVFZSA-N
  • GW 427353
  • Solabegron-d8 HCl
  • Solabegron 13C2 D4
  • Solabegron-d8
  • 3 '- [[2 - [(2R) - 2 - (3-chlorophenyl) - 2-hydroxyethyl] amino] ethyl] amino] - [1,1' - biphenyl] - 3-carboxylic acid
  • inhibit,GW-427353,Inhibitor,Adrenergic Receptor,GW427353,Beta Receptor,Solabegron
  • 252920-94-8
Copyright 2019 © ChemicalBook. All rights reserved